Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT02024932
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2013-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-29
First Submit QC Date:
None
Study First Post Date:
2013-12-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-12
Results First Submit QC Date:
None
Results First Post Date:
2017-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-09
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL